Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,153
archived clinical trials in
Gout

Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Boston, MA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Jackson, MS
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Helena, MT
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Helena, MT
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Henderson, NV
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Albuquerque, NM
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
New York, NY
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Ashville, NC
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Cleveland, OH
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Tulsa, OK
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Portland, OR
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Charleston, SC
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Dallas, TX
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Norfolk, VA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Seattle, WA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Huntington, WV
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Huntington, WV
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Single and Multiple Dose Study in Japanese Subjects
A Phase 1, Randomized, Single-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of RDEA3170 in Healthy Male Japanese Subjects
Status: Enrolling
Updated:  7/23/2013
Clinical Research Facility
mi
from
Glendale, CA
Single and Multiple Dose Study in Japanese Subjects
A Phase 1, Randomized, Single-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of RDEA3170 in Healthy Male Japanese Subjects
Status: Enrolling
Updated: 7/23/2013
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
RDEA3170 Monotherapy in Subjects With Gout
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of RDEA3170 Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  8/20/2013
Clinical Research Facility
mi
from
Charleston, SC
RDEA3170 Monotherapy in Subjects With Gout
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of RDEA3170 Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 8/20/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
NSAID Drug Interaction Study
A Phase 1 Study to Evaluate the Potential Two-Way Pharmacokinetic Interaction Between Lesinurad and Naproxen and Between Lesinurad and Indomethacin in Healthy Adult Male Subjects
Status: Enrolling
Updated:  10/4/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
NSAID Drug Interaction Study
A Phase 1 Study to Evaluate the Potential Two-Way Pharmacokinetic Interaction Between Lesinurad and Naproxen and Between Lesinurad and Indomethacin in Healthy Adult Male Subjects
Status: Enrolling
Updated: 10/4/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Impact of Unapproved Drug Initiative on Colchicine Use
Impact of Unapproved Drug Initiative on Colchicine Use
Status: Enrolling
Updated:  11/26/2013
Stanford Hospital and Clinics
mi
from
Stanford, CA
Impact of Unapproved Drug Initiative on Colchicine Use
Impact of Unapproved Drug Initiative on Colchicine Use
Status: Enrolling
Updated: 11/26/2013
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
A Phase 2, Open-label, Drug-Drug Interaction Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination With Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
Status: Enrolling
Updated:  9/26/2014
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
A Phase 2, Open-label, Drug-Drug Interaction Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination With Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
Status: Enrolling
Updated: 9/26/2014
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated:  10/4/2014
Miami Research Associates
mi
from
South Miami, FL
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated: 10/4/2014
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated:  10/4/2014
MRA Clinical Research
mi
from
Miami, FL
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated: 10/4/2014
MRA Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated:  10/4/2014
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated: 10/4/2014
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated:  10/4/2014
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
A Randomized, Double Blind, Third Party Open, Placebo Controlled Multi-center Study Of Efficacy, Safety And Tolerability Of Pf-06743649 In Gout Subjects
Status: Enrolling
Updated: 10/4/2014
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Food Effect Study of Febuxostat XR in Healthy Participants
A Phase 1, Open-Label, Single-Center, Randomized, 3-Way Crossover Study to Assess the Effect of Food on the Bioavailability of a Single Oral Dose of 80 mg Febuxostat Extended-Release Formulation and the Pharmacokinetics of a Single Oral Dose of 40 mg and 80 mg Febuxostat Extended-Release Formulation in Healthy Subjects
Status: Enrolling
Updated:  3/10/2015
Clinical Research Facility
mi
from
Austin, TX
Food Effect Study of Febuxostat XR in Healthy Participants
A Phase 1, Open-Label, Single-Center, Randomized, 3-Way Crossover Study to Assess the Effect of Food on the Bioavailability of a Single Oral Dose of 80 mg Febuxostat Extended-Release Formulation and the Pharmacokinetics of a Single Oral Dose of 40 mg and 80 mg Febuxostat Extended-Release Formulation in Healthy Subjects
Status: Enrolling
Updated: 3/10/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Status: Enrolling
Updated:  7/17/2015
University of South Florida Medical Clinics
mi
from
Tampa, FL
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Status: Enrolling
Updated: 7/17/2015
University of South Florida Medical Clinics
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Lincoln, CA
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Lincoln, CA
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Palo Alto, CA
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Boca Raton, FL
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Miami, FL
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Honolulu, HI
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Baltimore, MD
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Brockton, MA
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Brockton, MA
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
St. Louis, MO
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Hartsdale, NY
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Hartsdale, NY
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
New York, NY
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Durham, NC
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
San Antonio, TX
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
West Jordan, UT
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated:  9/3/2015
Research Site
mi
from
Burnaby,
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MBX-102 in Combination With Allopurinol in Gout Patients With an Inadequate Hypouricemic Response to Allopurinol Alone
Status: Enrolling
Updated: 9/3/2015
Research Site
mi
from
Burnaby,
Click here to add this to my saved trials
Mild, Moderate and Severe Renal Impairment Study
A Phase 1, Single-Dose, Open Label, Pharmacokinetic and Pharmacodynamic Study of RDEA3170 in Adult Male Subjects With Mild, Moderate, and Severe Renal Impairment
Status: Enrolling
Updated:  11/10/2015
Clinical Research Facility
mi
from
Lakewood, CO
Mild, Moderate and Severe Renal Impairment Study
A Phase 1, Single-Dose, Open Label, Pharmacokinetic and Pharmacodynamic Study of RDEA3170 in Adult Male Subjects With Mild, Moderate, and Severe Renal Impairment
Status: Enrolling
Updated: 11/10/2015
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials